에 대한 최신 뉴스 Equillium (NASDAQ:EQ) 주식

Equillium

Equillium Inc is a biotechnology developing therapies to treat severe autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph2-ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.

Equillium Inc

Invesco Russell 1000 Equal Weight ETF

EQT AB

Equity Bancshares, Inc. Class A Common Stock

Equity Bancshares Inc

Mensa Mining Corp

Equity Commonwealth Common Shares of Beneficial Interest

Equity Commonwealth

EQUITABLE FINCL CORP by Equitable Financial Corp.

Equitable Financial Corp

EQB Inc

Equitable Holdings Inc

Equitable Holdings, Inc. Depositary Shares

Equitable Holdings, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

Columbia U.S. Equity Income ETF

EQUINITI GROUP PLC ADR by Equiniti Group PLC

Equinix Inc

ALPS Equal Sector Weight ETF

EQ Labs Inc

Simplify Exchange Traded Funds Simplify Market Neutral Equity Long/Short ETF

iShares Trust iShares MSCI Emerging Markets Quality Factor ETF

EQUITY METALS CORPORATION by Equity Metals Corporation

Equity Metals Corp

Equinor ASA

EQUINOX RES LTD by EQUINOX RES LTD

Eqonex Ltd

Equity Residential Common Shares of Beneficial Interest

Equity Residential

ProShares Equities for Rising Rates ETF

EQRX INC COM

EQRX INC WT EXP

Equus Total Return Inc

EQS GROUP AG by EQS GROUP AG

EQT Corp

Equal Trading Inc

EQM TECHS & ENERGY INC by EQM Technologies & Energy, Inc.

EQM Technologies & Energy Inc

EQUITECH INTL CORP by Equitech Int'l Corp.

Equitech International Corp

Equitrans Midstream Corp PRF PERPETUAL USD - Ser 4/A2

ALTAMIRE GOLD CORP ORD by Altamira Gold Corp

Altamira Gold Corp

Lake Winn Resources Corp

LAKE WINN RESOURCES CORP by Lake Winn Resources Corp

Valued Advisers Trust Kovitz Core Equity ETF

QuadrantProtocol

EQUATORIAL ENERGIA S/ADR by Equatorial Energia S.A.

Equatorial SA

IndexIQ ETF Trust NYLI Engender Equality ETF

E-Qure Corp

EQV Ventures Acquisition Corp. Class A Ordinary Shares

EQV Ventures Acquisition Corp

EQV Ventures Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant

EQV Ventures Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

Invesco S&P 100 Equal Weight ETF

Equinox Gold Corp

Equalizer

Rockwell Automation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) shares surged after the company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43588368/rockwell-automation-reports-first-quarter-2025-results" rel="noreferrer noopener">better-than-expected first-quarter results.</a>
Sales fell 8.4% year over year and slid 7.6% organically to $1.881 billion, in line with the consensus of $1.881 billion.
Segment Details: Intelligent Devices sales declined 13.1% to $806 million, Software &amp; Control fell 12.4% to $529 million, and Lifecycle Services rose 5% to $546 million.
Total ARR grew 11%. Adjusted EPS was $1.83 (-10% YoY), <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">above the analyst consensus of $1.59.</a>
Total segment operating earnings for the quarter fell 10% year-over-year to $321 million. Segment operating margin declined slightly to 17.1% from 17.3%, impacted by lower sales volume, though partially offset by cost reductions and margin expansion efforts.
Operating cash flow was $364 million, up from $33 million year over year. Free cash flow reached $293 million, compared to a $35 million outflow last year. The increase was mainly due to no payout of incentive compensation in the&nbsp;first quarter&nbsp;of fiscal 2025 related to fiscal 2024 performance.
&#8220;From a demand perspective, we are encouraged by better-than-expected order performance in the quarter with sequential growth across all regions and business segments. While there is still some macroeconomic and policy uncertainty weighing on customers' capex plans, Rockwell won multi-million dollar strategic orders across key industries, especially in the U.S., our home market,&#8221; commented Blake Moret, Chairman and CEO.
&#8220;Q1 margins and EPS came in well above our expectations this quarter, reflecting some early benefits of Rockwell&#8217;s renewed focus on operational excellence and cost discipline,&#8221; added Moret.
The company repurchased 0.4 million shares for $99 million during the quarter. As of December 31, $1.2 billion remained under existing repurchase authorizations.
Return on Invested Capital for the twelve months ended December 31, 2024, was 14.5%, down from 18.5% in the prior year, primarily due to lower pre-tax net income.
FY25 Outlook updates: Rockwell continues to expect adjusted EPS of $8.60 – $9.80 versus the $9.40 estimate.
The company lowered sales midpoint expectations to ~$8.1 billion from the prior view of ~$8.2 billion <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">versus the $8.225 billion estimate.</a>
The company updated fiscal 2025 reported sales growth range to (5.5)% &#8211; 0.5% due to ~(1.5)% FX impact to sales, reaffirmed organic sales growth range of (4)% &#8211; 2%.
Price Action: ROK shares are trading higher by 9.36% at $293.51 at the last check Monday.
Photo via Shutterstock.

Earnings

Equities

News

Guidance

Movers

Rockwell Automation Defies Q1 Sales Decline With Cost Discipline And Strong Cash Flow; Stock Jumps

Monday.com Ltd&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) reported fiscal fourth-quarter 2024 revenue growth of 32% year-on-year to $267.98 million, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43588350/monday-com-announces-fourth-quarter-and-fiscal-year-2024-results" rel="noreferrer noopener">analyst consensus estimate of $261.37 million</a>.&nbsp;
The project management software&nbsp;company&#8217;s&nbsp;adjusted EPS of $1.08 beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $0.79</a>. The&nbsp;stock price climbed after the results.
Also Read: <a href="https://www.benzinga.com/25/02/43561852/cboe-q4-earnings-growth-driven-by-strong-options-trading-and-global-equities-ceo-highlights-market-expansion" target="_blank" rel="noreferrer noopener">Cboe Q4 Earnings: Options Boom, Global Growth, Market Expansion Drive Gains</a>
The net dollar retention rate was 112%&nbsp;and 115%&nbsp;for customers with more than ten users.
The number of paid customers with over $50,000 in annual recurring revenue (ARR) rose 39%&nbsp;year over year&nbsp;to 3,201. The adjusted operating margin increased 500 bps to 15%.
In the quarter, Monday.com generated:
<ul>
<li>Operating cash flow of $76.7 million</li>
<li>$72.7 million of free cash flow, compared to $58.5 million and $55.4 million, respectively, a year ago.</li>
<li>$1.46 billion in cash and equivalents as of Dec. 31, 2024.</li>
</ul>
Roy Mann and Eran Zinman, co-founders and co-CEOs, flagged the expansion of its product suite with Monday service, which is already seeing rapid adoption from both existing and new customers.
They also highlighted that the company doubled down on its AI efforts, focusing on AI Blocks, Product Power-ups, and a new Digital Workforce of AI Agents for 2025. They expect AI to be a game-changer for their customers, giving them the ability to transform their workflows and scale faster than ever before.
Outlook:&nbsp;Monday.com expects fiscal first-quarter 2025 revenue of $274 million—$274.32&nbsp;million (versus the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus of $246.1 million</a>) and an adjusted operating margin of 9%–10%.
Monday.com expects 2025 revenue of $1.208 billion—$1.221 billion, against the consensus of $1.210 billion, and an adjusted operating margin of 11%–12%.
Monday.com stock surged over 57% in the last 12 months. At least four Wall Street firms reduced their price target on the stock in 2025. However, Citigroup <a target="_blank" href="https://www.benzinga.com/quote/MNDY/analyst-ratings" rel="noreferrer noopener">upgraded its rating</a> from Neutral to Buy, and Cantor Fitzgerald initiated coverage on the stock with an Overweight.
Price Action: Monday.com stock is up 30.4% at $334.76 at the last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43535385/thomson-reuters-q4-earnings-beats-estimates-boosts-dividend-10-ceo-highlights-strategic-growth" target="_blank" rel="noreferrer noopener">Thomson Reuters Q4 Earnings: Beats Estimates, Boosts Dividend 10%, CEO Highlights Strategic Growth</a></li>
</ul>
Image: Shutterstock

MNDY

Monday.com Beats Q4 Earnings Estimates, Boasts 32% Revenue Growth: CEO Calls AI A Game-Changer

JMP Securities analyst Mitch Germain reiterates Terreno Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>) with a Market Outperform and maintains $72 price target.

Price Target

Reiteration

Analyst Ratings

TRNO

JMP Securities Reiterates Market Outperform on Terreno Realty, Maintains $72 Price Target

Scotiabank analyst Divya Goyal maintains Converge Tech Solns (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CTS#TSX">CTS</a>) with a Sector Perform and raises the price target from C$4 to C$5.5.

TSX:CTS

Scotiabank Maintains Sector Perform on Converge Tech Solns, Raises Price Target to C$5.5

Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) will release its fourth-quarter financial results after the <a href="https://www.benzinga.com/quote/AMKR/earnings">closing bell on Monday, Feb. 10.</a>
Analysts expect the Tempe, Arizona-based company to report quarterly earnings at 38 cents per share, down from 48 cents per share in the year-ago period. Amkor projects quarterly revenue of $1.66 billion, compared to $1.75 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 16, 2024, Amkor Technology named John Liu to Board of Directors.
Amkor shares fell 1.1% to close at $24.33 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>DA Davidson analyst Thomas Diffely maintained a Buy rating and cut the price target from $40 to $36 on Oct. 29, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Goldman Sachs analyst Toshiya Hari maintained a Neutral rating and cut the price target from $36 to $32 on Oct. 29, 2024. This analyst has an accuracy rate of 81%.</li>
<li>Keybanc analyst Steve Barger maintained an Overweight rating and lowered the price target from $38 to $34 on Oct. 29, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Morgan Stanley analyst Joseph Moore maintained an Equal-Weight rating and cut the price target from $35 to $26 on Oct. 29, 2024. This analyst has an accuracy rate of 71%.</li>
<li>Needham analyst Charles Shi maintained a Buy rating and lowered the price target from $45 to $34 on Oct. 29, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying AMKR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="484" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10051127/image-74-1024x484.png" alt="" class="wp-image-774174" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10051127/image-74-1024x484.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10051127/image-74-300x142.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10051127/image-74-768x363.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10051127/image-74.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a></li>
</ul>

Markets

Trading Ideas

AMKR

Amkor Technology Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

WIIM

GSAT

Globalstar shares are trading higher after MDA Space signed a definitive contract with the company to be the prime contractor for the satellite operator's next generation low Earth orbit constellation.

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 100 points on Monday.
Following the market opening Monday, the Dow traded up 0.24% to 44,407.91 while the NASDAQ gained 0.89% to 19,696.41. The S&amp;P 500 also rose, gaining, 0.43% to 6,051.88.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a>
Leading and Lagging Sectors Information technology shares surged by 1.5% on Monday.
In trading on Monday, real estate shares fell by 0.7%.
Top Headline
Shares of McDonald's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) gained around 5% on Monday following the release of fourth-quarter results.
The company reported a fourth-quarter sales decline of 0.3% year-on-year to $6.388 billion, missing the analyst consensus estimate of $6.442 billion. Adjusted EPS of $2.83 was in line with the analyst consensus estimate.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares shot up 107% to $0.8625.</li>
<li>Shares of Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>)got a boost, surging 70% to $6.93 after the company announced it received FDA fast-track designation for eRapa.</li>
<li>Global Star Acquisition, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLST#NASDAQ">GLST</a>) shares were also up, gaining 58% to $17.32.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares dropped 60% to $3.1075. On Friday, Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and stiffening of the lung tissue.</li>
<li>Shares of FBS Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) were down 33% to $1.2050.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was down, falling 31% to $37.46 after Needham cut its price target on the stock from $74 to $54.</li>
</ul>
Commodities In commodity news, oil traded up 1.4% to $71.99 while gold traded up 1.5% at $2,931.10.
Silver traded up 0.6% to $32.635 on Monday, while copper rose 2% to $4.6820.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX 40 rose 0.6% and France's CAC 40 rose 0.3%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 rose 0.8%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.04%, China's Shanghai Composite Index climbing 0.56%, Hong Kong's Hang Seng Index gaining 1.84% and India's BSE Sensex falling 0.70%.
Economics
Data on US consumer inflation expectations will be released today
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Eurozone

Commodities

Intraday Update

BDRX

BNAI

FBGL

GLST

PLRX

SMTC

Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results

Vertex Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) is set to report <a href="https://www.benzinga.com/quote/VRTX/earnings">fourth quarter earnings</a> after the market closes Monday. Biotech investors are bracing for impact.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085744/Screenshot-2025-02-10-at-7.27.22-PM.png" alt="" class="wp-image-774596" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085744/Screenshot-2025-02-10-at-7.27.22-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085744/Screenshot-2025-02-10-at-7.27.22-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
The stock has climbed 15.66% year-to-date, recovering from last year's volatility. With selling pressure creeping in, the question is whether this rally has legs, or if it&#8217;s time for a reset.
<h2 class="wp-block-heading">Wall Street's Expectations: Solid Numbers Or A Reality Check?</h2>
Wall Street expects Vertex to post EPS of $4.03 on revenue of $2.78 billion, per <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1">Benzinga Pro</a> data. 
But beyond the numbers, the real focus is on the company's upcoming drug launches and how they could fuel future growth.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43526731/unitedhealth-vertex-pharmaceuticals-axon-enterprise-and-a-major-energy-stock-cnbcs-final-trades">UnitedHealth, Vertex Pharmaceuticals, Axon Enterprise And A Major Energy Stock: CNBC&#8217;s &#8216;Final Trades&#8217;</a>
<h2 class="wp-block-heading">Pipeline Watch: Can Alyftrek And Suzetrigine Deliver?</h2>
JPMorgan analyst Jessica Fye sees 2025 as a make-or-break year for Vertex.
The company is rolling out Alyftrek, its latest cystic fibrosis (CF) treatment and preparing for a potential suzetrigine launch in acute pain. Investors will be watching management's commentary on these new products closely, especially after suzetrigine's mixed Phase II results in LSR (large sensory neuropathy).
Fye expects a solid launch for Alyftrek, modeling $376 million in 2025 revenue though but suzetrigine's adoption remains uncertain, with pricing a key factor.
<h2 class="wp-block-heading">VRTX Stock Technicals: Bullish, But With Risks</h2>
Technicals are giving mixed signals. VRTX stock is trading at $469.32, above its eight-day, 20-day, 50-day and 200-day moving averages, flashing buy signals across the board.
The MACD (moving average convergence/divergence) indicator is bullish. RSI (relative strength index) at 62.06 suggests there&#8217;s still room to run.
But selling pressure is creeping in, hinting at potential turbulence ahead.
<h2 class="wp-block-heading">Can Vertex Stock Keep Its Momentum?</h2>
Vertex needs to deliver more than just a solid quarter though investors want confidence in its 2025 pipeline. Any slip-up in guidance could shake the stock's recent momentum. Stay tuned.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43589292/top-wall-street-forecasters-revamp-vertex-pharmaceuticals-price-expectations-ahead-of-q4-earnings">Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Biotech

Health Care

Technicals

Previews

Tech

General

VRTX

Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?

JMP Securities analyst Matthew Carletti reiterates Skyward Specialty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKWD#NASDAQ">SKWD</a>) with a Market Outperform and maintains $60 price target.

SKWD

JMP Securities Reiterates Market Outperform on Skyward Specialty, Maintains $60 Price Target

JMP Securities analyst Greg Miller reiterates Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) with a Market Outperform and maintains $220 price target.

JMP Securities Reiterates Market Outperform on Digital Realty Trust, Maintains $220 Price Target

GameStop shares are trading higher amid speculation after Ryan Cohen posted a picture with Michael Saylor.

Shares of Macom Technology Solutions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) came under pressure, despite in-line fiscal first-<a href="https://www.benzinga.com/topic/semiconductors">quarter results and outlook</a>.
Rival Semtech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) disclosed lower IC (integrated circuit) sales into Active Copper Cables, according to Northland Capital Partners.
The Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590c74bd290fa70001c93005/tim-savageaux">Analyst Tim Savageaux</a> upgraded the rating for Macom Technology Solutions from Market Perform to Outperform, while raising the price target to $140.
The Thesis: The company's first-quarter revenue grew by 9% sequentially and 39% year-on-year to $218.1 million, Savageaux said in the upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The sequential growth in revenues was driven by Datacom, while year-on-year growth was led by an around 80% increase in Telecom revenues due to the Wolfspeed acquisition and strong growth in Industrial/Defense revenues, he added.
"MTSI noted its third consecutive quarter with a 1.10 book to bill, the analyst stated. "MTSI noted expectations for an expansion of its AI Datacom customer base at 800G, which to date has been focused on major China module makers, as well as a ramp in solutions supporting 1.6T connectivity over the next Qs," he further wrote.
"We look to take advantage of any weakness given strong bookings and multiple growth vectors including AI Optical, Satcom and Defense," the analyst stated.
Price Action: Shares of Macom Technology Solutions had declined by 0.76% to $126.24 at the time of publication on Monday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42953261/nvidia-broadcom-and-marvell-positioned-for-growth-as-ai-demand-drives-semiconductor-momentum">Nvidia, Broadcom, Marvell Positioned For Growth As AI Demand Drives Semiconductor Momentum</a></li>
</ul>
Image: Shutterstock

Topics

MTSI

Macom Technology Solutions Is Poised For AI-Driven Revenue Growth: Analyst

High-rolling investors have positioned themselves bearish on Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in NET often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 18 options trades for Cloudflare. This is not a typical pattern.
The sentiment among these major traders is split, with 27% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $28,500, and 17 calls, totaling $736,409.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $200.0 for Cloudflare during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Cloudflare's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cloudflare's whale trades within a strike price range from $90.0 to $200.0 in the last 30 days. 
<h3>Cloudflare 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739200529_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$12.05</td>
<td>$11.1</td>
<td>$11.75</td>
<td>$200.00</td>
<td>$84.6K</td>
<td>167</td>
<td align="right">104</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$81.5</td>
<td>$80.8</td>
<td>$80.8</td>
<td>$100.00</td>
<td>$80.8K</td>
<td>31</td>
<td align="right">10</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$55.55</td>
<td>$52.7</td>
<td>$54.68</td>
<td>$120.00</td>
<td>$54.6K</td>
<td>204</td>
<td align="right">10</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$51.0</td>
<td>$49.2</td>
<td>$51.0</td>
<td>$115.00</td>
<td>$51.0K</td>
<td>2.0K</td>
<td align="right">10</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$15.35</td>
<td>$13.5</td>
<td>$15.0</td>
<td>$200.00</td>
<td>$48.0K</td>
<td>102</td>
<td align="right">32</td>
</tr>
</tbody>
</table>

<h3>About Cloudflare</h3>
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
In light of the recent options history for Cloudflare, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Cloudflare</h3>
<ul>
<li>With a volume of 1,252,282, the price of NET is up 2.21% at $170.35. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 80 days.</li>
</ul>
<h3>Expert Opinions on Cloudflare</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $134.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Guggenheim keeps a Sell rating on Cloudflare with a target price of $68. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Cloudflare with a target price of $170. 
&#x2A; Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Neutral rating on Cloudflare with a target price of $149. 
&#x2A; An analyst from Citigroup has elevated its stance to Buy, setting a new price target at $145. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Cloudflare, targeting a price of $140. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cloudflare, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Decoding Cloudflare's Options Activity: What's the Big Picture?

Whales with a lot of money to spend have taken a noticeably bearish stance on Snowflake.
Looking at options history for Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 53% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $89,300 and 11, calls, for a total amount of $789,557.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $170.0 and $200.0 for Snowflake, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Snowflake's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Snowflake's substantial trades, within a strike price spectrum from $170.0 to $200.0 over the preceding 30 days.
<h3>Snowflake Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739200524_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$18.0</td>
<td>$17.35</td>
<td>$17.7</td>
<td>$180.00</td>
<td>$177.0K</td>
<td>3.6K</td>
<td align="right">109</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$10.5</td>
<td>$10.3</td>
<td>$10.3</td>
<td>$200.00</td>
<td>$176.1K</td>
<td>9.7K</td>
<td align="right">285</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$25.2</td>
<td>$24.85</td>
<td>$24.85</td>
<td>$170.00</td>
<td>$149.1K</td>
<td>10.3K</td>
<td align="right">61</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$21.3</td>
<td>$21.1</td>
<td>$21.1</td>
<td>$185.00</td>
<td>$63.3K</td>
<td>529</td>
<td align="right">31</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$14.05</td>
<td>$13.95</td>
<td>$13.95</td>
<td>$190.00</td>
<td>$55.8K</td>
<td>229</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Snowflake</h3>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
After a thorough review of the options trading surrounding Snowflake, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Snowflake's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,152,682, the SNOW's price is up by 0.92%, now at $185.72. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 16 days.</li>
</ul>
<h3>Professional Analyst Ratings for Snowflake</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $200.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $201. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Snowflake, targeting a price of $200. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Snowflake with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

SNOW

Market Whales and Their Recent Bets on SNOW Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Trade Desk.
Looking at options history for Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) we detected 16 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $495,265 and 7, calls, for a total amount of $528,442.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $80.0 to $180.0 for Trade Desk during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Trade Desk stands at 361.42, with a total volume reaching 2,366.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Trade Desk, situated within the strike price corridor from $80.0 to $180.0, throughout the last 30 days.
<h3>Trade Desk Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739200518_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$17.35</td>
<td>$15.95</td>
<td>$16.25</td>
<td>$180.00</td>
<td>$162.5K</td>
<td align="right">262</td>
<td align="right">250</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$6.95</td>
<td>$5.65</td>
<td>$5.85</td>
<td>$130.00</td>
<td>$117.0K</td>
<td align="right">10</td>
<td align="right">205</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$7.95</td>
<td>$7.15</td>
<td>$7.8</td>
<td>$120.00</td>
<td>$117.0K</td>
<td align="right">1</td>
<td align="right">153</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$10.65</td>
<td>$10.3</td>
<td>$10.5</td>
<td>$117.00</td>
<td>$73.5K</td>
<td align="right">180</td>
<td align="right">73</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.8</td>
<td>$17.7</td>
<td>$17.7</td>
<td>$120.00</td>
<td>$70.8K</td>
<td align="right">462</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About Trade Desk</h3>
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on different devices like computers, smartphones, and connected TVs. It utilizes data to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry. The firm generates its revenue from fees based on a percentage of what its clients spend on advertising.
Following our analysis of the options activities associated with Trade Desk, we pivot to a closer look at the company's own performance.
<h3>Where Is Trade Desk Standing Right Now?</h3>
<ul>
<li>With a volume of 1,072,397, the price of TTD is up 4.28% at $122.31. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 2 days.</li>
</ul>
<h3>What The Experts Say On Trade Desk</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $147.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Trade Desk with a target price of $160. 
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Trade Desk with a target price of $142. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Trade Desk, targeting a price of $142. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Trade Desk, maintaining a target price of $145. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Trade Desk with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Behind the Scenes of Trade Desk's Latest Options Trends

Shaquille O'Neal is a <a href="https://www.benzinga.com/personal-finance/25/01/43077262/nba-legend-shaq-spotted-a-young-man-buying-an-engagement-ring-in-zales-when-he-swooped-in-and-paid-for-it-tell-your-girlfriend-i-got-it">generous man</a>, but he's not raising "nepo babies." His kids are going to earn their way, and as he famously says, "In order to get my cheese, <a href="https://www.benzinga.com/personal-finance/24/08/40658562/nba-legend-shaq-tells-his-kids-in-order-to-get-my-cheese-you-have-to-present-me-with-two-degrees">you gotta have two degrees</a>." That's the rule, and it applies to all of them—except, well, his daughters get a little extra motivation.
During his appearance on <a href="https://www.youtube.com/watch?v=Tl9uWnqVizo">The Jennifer Hudson Show</a> in October 2023, Shaq opened up about how he handles money with his six kids. While they're all "wonderful" and don't give him any problems, they're not always thrilled with his approach.
"They're kind of upset with me," Shaq admitted. "They're like, ‘You treat the girls different.' And I was like, ‘You damn right I do. Damn right I do.'"
Don't Miss:
<ul>
<li>The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
For Shaq, there's a clear difference when it comes to how he <a href="https://www.benzinga.com/personal-finance/24/09/40943843/we-aint-rich-im-rich-nba-legend-shaq-says-his-daughters-and-sons-dont-get-equal-treatment-my-boy">supports his daughters versus his sons</a>.
"You have to protect and provide for the ladies," he explained. "So I give them incentive packages."
And those incentives? They come with a purpose. Shaq isn't just handing out money—he's making deals. He turned to the camera and sent a direct message to his daughters.
"I know they're watching. Daddy wants you to go to law school. He'll hook you up."
Shaq has made it clear that financial security isn't a given in his household. His kids have to earn it. His famous "two degrees" rule means they need to prove themselves academically before they can touch his fortune. But while his sons are expected to grind it out, his daughters get extra incentives to push them toward success.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
They might not always like it, but Shaq doesn't seem to be changing his approach anytime soon. If anything, he's doubling down. When his kids call him asking for money? His response is simple.
"I be like, ‘I ain't got it. Daddy broke. I ain't got it.'"
While Shaq jokingly tells his kids he's "broke," the reality couldn't be further from the truth. He's sitting on a fortune, but don't expect him to hand it over without a fight. His wealth <a href="https://www.benzinga.com/real-estate/25/01/43008676/has-early-google-investor-shaquille-oneal-found-his-next-big-winner-in-tech-stocks">isn't just from basketball</a>—it's from years of smart business moves, investments, and an unshakable work ethic.
See Also: They call it the &#8216;Biggest Disruption To IP Since Disney&#8217; and their funding window is closing . <a href="https://www.benzinga.com/money/elf-labs-1">Less than 10 days for investors to claim shares at just $2/share with $980 minimum.</a>
From his restaurant chain, Big Chicken, which just locked in a $37.5 million valuation, to his early bets on companies like Google and Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Shaq plays the long game. He's not just collecting checks; he's building an empire. According to <a href="https://sharpsheets.io/blog/what-franchises-does-shaq-oneal-own/">Sharpsheets</a>, he still owns nine Papa John's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PZZA#NASDAQ">PZZA</a>)&nbsp; locations and a Krispy Kreme (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) in Atlanta, and while he once owned 155 Five Guys, he sold them off to reinvest elsewhere. His philosophy? If it's not making an impact, it's not worth his time.
Shaq's mindset is clear: work for what you want. That's why his kids won't see a dime until they've earned it. And even then, they better believe he's going to make sure they put it to good use.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
</ul>

Personal Finance

AAPL

DNUT

PZZA

NBA Legend Shaq Says 'Damn Right' His Daughters Get Special Financial Treatment And 'Incentive Packages' — But Not His Sons

McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) has outperformed the market over the past 20 years by 6.52% on an annualized basis producing an average annual return of 14.92%. Currently, McKesson has a market capitalization of $75.62 billion. 
Buying $100 In MCK: If an investor had bought $100 of MCK stock 20 years ago, it would be worth $1,621.13 today based on a price of $595.69 for MCK at the time of writing.
<h3>McKesson's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739200510_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In McKesson 20 Years Ago Would Be Worth This Much Today

Macro Economic Events

Global

Economics

Mexico President Claudia Sheinbaum Says We Are Going To Wait To Hear If Trump Announces Tariffs On Steel And Aluminum Imports

JMP Securities analyst Daniel Stauder reiterates AtriCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) with a Market Outperform and maintains $60 price target.

ATRC

JMP Securities Reiterates Market Outperform on AtriCure, Maintains $60 Price Target

Pliant Therapeutics shares are trading lower after the company paused enrollment in its BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Equillium (EQ – Research Report), Foghorn Therapeuti...

Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)

Equillium says Ono not acquiring itolizumab, stock craters 36%

JonesResearch downgraded Equillium (EQ) to Hold from Buy without a price target after the company announced that Ono Pharmaceutical (OPHLY) decline...

Equillium downgraded to Hold from Buy at JonesResearch

In a report released yesterday, Dae Gon Ha from Stifel Nicolaus maintained a Buy rating on Equillium (EQ – Research Report), with a price target of...

Equillium (EQ) Gets a Buy from Stifel Nicolaus

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Equillium (EQ – Research Report), Quest Diagnostic...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (EQ), Quest Diagnostics (DGX) and Alnylam Pharma (ALNY)

Reports Q3 revenue $12.2M, consensus $15.4M. "At the end of October we announced that our partnership with Ono Pharmaceutical had ended following s...

Equillium reports Q3 EPS 0c, consensus (26c)

Equillium ( ($EQ) ) has released its Q3 earnings. Here is a breakdown of the information Equillium presented to its investors. Equillium, Inc., a b...

Equillium's Q3 Financials and Clinical Progress in Focus

Equillium ( ($EQ) ) has shared an update. Equillium, Inc. announced changes in its Board of Directors with the resignation of Yu (Katherine) Xu, Ph...

Equillium Announces Board and Audit Committee Changes

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ulcerative ...

Comments

Equillium

뉴스

에 대한 최신 뉴스 Equillium (NASDAQ:EQ) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌